- freely available
Int. J. Mol. Sci. 2012, 13(8), 9808-9825; doi:10.3390/ijms13089808
Abstract: Prohibitin (PHB) and paired box 2 (PAX2) are associated with the development of renal interstitial fibrosis (RIF). This study was performed to investigate whether or not the PHB could regulate the PAX2 gene expression in unilateral ureteral obstruction (UUO) in rats. Eighty Wistar male rats were randomly divided into two groups: sham operation group (SHO) and model group subjected to unilateral ureteral obstruction (GU), n = 40, respectively. The model was established by left ureteral ligation. Renal tissues were collected at 14-day and 28-day after surgery. RIF index, protein expression of PHB, PAX2, transforming growth factor-βl (TGF-β1), α-smooth muscle actin (α-SMA), collagen-IV (Col-IV), fibronectin (FN) or cleaved Caspase-3, and cell apoptosis index in renal interstitium, and mRNA expressions of PHB, PAX2 and TGF-β1 in renal tissue were detected. When compared with those in SHO group, expression of PHB (mRNA and protein) was significantly reduced, and expressions of PAX2 and TGF-β1 (protein and mRNA) were markedly increased in the GU group (each p < 0.01). Protein expressions of α-SMA, Col-IV, FN and cleaved Caspase-3, and RIF index or cell apoptosis index in the GU group were markedly increased when compared with those in the SHO group (each p < 0.01). The protein expression of PHB was negatively correlated with protein expression of PAX2, TGF-β1, α-SMA, Col-IV, FN or cleaved Caspase-3, and RIF index or cell apoptosis index (all p < 0.01). In conclusion, less expression of PHB is associated with increased PAX2 gene expression and RIF index in UUO rats, suggesting that increasing the PHB expression is a potential therapeutic target for prevention of RIF.
Renal interstitial fibrosis (RIF) is the major histopathological change seen in a variety of renal disorders and is closely related to renal dysfunction . Tubule-interstitial changes, including tubular degeneration and interstitial cell infiltration, are a hallmark of common progressive chronic diseases that lead to renal failure . The elevation of transforming growth factor-β1 (TGF-β1), α-smooth muscle actin (α-SMA) and extracellular matrix (ECM) in renal interstitium is the most important feature of RIF. However, the exact mechanism is complicated and is not well elucidated at the moment.
Prohibitin (PHB, also known as PHB1), a member of the Band-7 family of proteins, is highly conserved evolutionarily, widely expressed, and present in different cellular compartments . It plays a pivotal role in the processes of cell differentiation and apoptosis . The over-expression of PHB could protect the mitochondria from oxidative stress-induced injury . When the function of mitochondria is confused, more reactive oxygen species (ROS) will be released from the mitochondria. ROS from mitochondria is a strong agent to induce the expression of TGF-β1 and promotes TGF-β1-dependent myofibroblast differentiation . Over-expression of PHB could suppress renal interstitial fibroblasts proliferation and halt the progression of RIF . So, PHB might take part in the development and progression of RIF.
Paired box gene 2, PAX2, encodes for a transcription factor that is up-regulated during nephrogenesis and becomes silenced in mature epithelium of the glomeruli, the proximal tubule, and distal tubule [8,9]. PAX2 is essential for development of the urogenital system, embryo, inner ear, neural tube, optic vesicle, optic cup and optic tract [10–12]. PAX2 has been implicated as an oncogene in carcinomas of the kidney, prostate, breast, ovary and so on . Interestingly, ROS can induce the PAX2 expression [14,15] and the over-expression of PAX2 is found in the renal tissue suffering from RIF . PAX2 is associated with the development of RIF.
From the above (PHB or PAX2 was associated with ROS, furthermore, PHB or PAX2 was associated with RIF), we drew a hypothesis that there was an association between PHB and PAX2 in the progression of RIF. This investigation was conducted to explore whether or not PHB was associated with the gene expression of PAX2 in UUO rats.
2.1. Renal Morphology
More collagen deposition, fibroblast proliferation and diffused lymphoeytein filtration in the renal interstitium of GU group were observed when compared with those in SHO group (Figure 1). The index of RIF in GU was notably elevated when compared with that in SHO (p < 0.01; Figure 2).
2.2. Protein Expression of PHB, PAX2, TGF-βl, α-SMA, Col-IV, FN or Cleaved Caspase-3
When compared with SHO, in GU group the protein expression of PHB in renal interstitium was significantly weakened (p < 0.01, Figures 1 and 2) and the protein expressions of PAX2, TGF-βl, α-SMA, Col-IV, FN and cleaved Caspase-3 in renal interstitium were significantly increased (all p < 0.01, Figures 1 and 2). PHB, PAX2 and cleaved Caspase-3 were mainly located in the renal tubular epithelial cells (RTEC) in our observation (Figure 1).
2.3. Cell Apoptosis
The staining for cell apoptosis was much more significant in renal interstitium in GU group than that in SHO group (Figure 1), and the apoptosis index was significantly increased in GU group when compared with that in SHO (p < 0.01, Figure 2). Interestingly, the apoptotic cell in our observation was mainly derived from RTEC (Figure 1).
2.4. mRNA Expression of PHB, PAX2 or TGF-βl
Renal tissue of GU group showed consistently lower PHB mRNA expression and higher PAX2 or TGF-βl mRNA expression, when compared to those in SHO respectively (all p < 0.01; Figure 2). The amplification curve and melting curve for PHB, PAX2, TGF-βl and β-actin were shown in Figure 3.
2.5. Correlation Analysis
There was a negatively correlation between PHB protein and index of RIF, protein expression of PAX2, TGF-βl, α-SMA, Col-IV, FN or cleaved Caspase-3, or cell apoptosis index (r = −0.825, −0.798, −0.817, −0.786, −0.948, −0.953, −0.863, −0.886; each p < 0.01). PAX2 protein level was positively correlated with RIF index, TGF-βl, α-SMA, Col-IV, FN or cleaved Caspase-3, or cell apoptosis index (r = 0.732, 0.833, 0.864, 0.757, 0.837, 0.902, 0.886; each p < 0.01).
RTEC, an important cell taking part in the process of RIF, suffers from ischemic injury [17,18] which can increase the production of ROS, and undergoes epithelial-mesenchymal transition (EMT) in RIF induced by UUO [19,20]. Over-expression and deposit of ECM, such as Col-IV and FN, are the important characteristics of RIF. RTEC suffering from EMT plays a crucial role in the progress of RIF [21,22]. α-SMA, as a specific marker for EMT, takes part in the development and progression of RIF [21,23]. Of all the cytokines and growth factors involved, TGF-β1 plays the most important role when compared with others, and the increased expression of TGF-β1 is closely correlated with the development of RIF [24,25]. TGF-β1 is known to be one of the major mediators and leads to RIF by inducing the production of α-SMA and ECM (Col-IV and FN) in renal interstitium [26–28]. So, TGF-β1, α-SMA, Col-IV and FN are the important indicators to evaluate the grade of RIF lesion and the progression of RIF. Cleaved Caspase-3 is a pivotal effector of the apoptosis machinery  and cleaved Caspase-3 activity was associated with cell apoptosis [30,31]. Cell apoptosis is most important for the development of RIF [32–34]. In this investigation, those indicators were evaluated.
In this study, we found that index of RIF, mRNA and protein expression of PAX2 or TGF-βl, protein expression of α-SMA, Col-IV, FN or cleaved Caspase-3, or cell apoptosis index were markedly increased in GU group when compared with those in SHO group, especially in 28-day. We also found the impaired RTEC was the main contributor for RIF in UUO model. A conclusion could confidently be drawn that the RIF model induced by UUO in our study was successful. However, the pathological mechanism of RIF was not elucidated.
PHB is a highly conserved, ubiquitously expressed protein that participates in diverse processes including mitochondrial chaperone, growth and apoptosis  and is regarded as an apoptosis-regulating protein . The PHB might have played a protective role against injury in cells or tissue in some studies. Ko et al.  found that hepatocyte-specific PHB deficiency resulted in marked liver injury, oxidative stress, and fibrosis with development of hepatocellular carcinoma, suggesting that PHB was a tumor suppressor in hepatocytes. Liu et al.  conducted a study in cardiomyocytes and their data indicated that PHB could protect the cardiomyocytes from oxidative stress-induced damage, and that increasing PHB content in mitochondria constituted a new therapeutic target for myocardium injury. Muraguchi et al.  performed an investigation in H9C2 cardiomyocytes and found that PHB might function as a survival factor against hypoxia-induced cell death. The results from the above mentioned studies drew a consistent conclusion that PHB could protect the cells or tissue from ROS-induced injury.
PHB might be expressed in renal tissue. There were also some observations found that PHB might be observed in renal tissue and that PHB might play a protective role in kidney against renal diseases. Guo et al.  observed that PHB protein was positively expressed in normal renal tissues, strongly down-regulated in renal biopsy specimens from patients, and negatively correlated with the expression of a-SMA and with the degrees of tubulointerstitial lesions. They also conducted a study in rat kidney fibroblasts cell line and found over-expression of PHB suppresses renal interstitial fibroblasts proliferation and cell phenotypic change induced by TGF-βl. Wu et al.  performed a study in rats with renal tubular atrophy and interstitial fibrosis induced by aristolochic acid and found that the expression of PHB protein was down-regulated in renal tissue of rats. Quan et al.  observed that the expression of Prohibitin-2 (homologue of PHB1 ) was down-regulated in RETC stimulated by elevated uric acid, which may promote trans-differentiation of renal tubular epithelial cells. Those reports consistently agreed that PHB was a protective factor, which is similar to our results. In this study, we found that PHB was mainly located in RTEC and was correlated negatively with protein expression of TGF-βl, α-SMA, Col-IV, FN or cleaved Caspase-3, index of RIF or cell apoptosis index. The PHB expression in normal control group was more notable when compared with that in GU group. In conclusion, PHB can suppress the development of RIF by alleviating the expression of TGF-βl (mRNA and protein), the protein expression of α-SMA, Col-IV, FN or cleaved Caspase-3, and can weaken the indexes of RIF and cell apoptosis.
PAX2, a nuclear transcription factor, was recently observed in renal interstitium and takes part in the development and progression of RIF. Normal expression of PAX2 is necessary for the regular development of renal tissue and kidney cells [41–43]. Some reports found that the expression of PAX2 was closely associated with some kidney diseases. Li et al.  conducted a study in rats with obstructive nephropathy and found that PAX2 was re-expressed in the renal tubules, which might participate in the pathogenesis of renal tubular damage and RIF. The result from Li et al. was similar to the result obtained in our investigation. Benetti et al.  performed a study of a 13-year-old boy suffering from familial juvenile hyperuricemic nephropathy and a renal biopsy showed that PAX2-positive immunostaining was notably seen at the corticomedullary junction and most of glomeruli featuring an enlargement of Bowman space (glomerular cysts), with mild interstitial fibrosis, inflammatory infiltrate, and focal tubular atrophy at the cortical level. Mure et al.  in a study of 26 fetal lambs performed surgical UUO and found that PAX2 protein was highly expressed in the nephrogenic zone, decreasing progressively to being markedly decreased in control lamb kidneys. Murer et al.  investigated 17 biopsies of juvenile nephronophthisis and observed that the failure of PAX2 repression involved in interstitial fibrosis and cysts formation. Huang et al.  explored the potential role of PAX2 in EMT that was induced in the remnant kidney of rats following 5/6 nephrectomy, and also examined PAX2 in cultured renal tubular epithelial cells, and their interesting experiments suggest that the re-expression of PAX2 in the tubular epithelial cells played an important role in the promotion of EMT, and there might a therapeutic value in silencing PAX2 to prevent or reverse renal fibrosis. Furthermore, ROS can induce PAX2 expression [14,15] and over-expression of PAX2 is found in the renal tissue suffering from RIF . PAX2 is associated with the development of RIF. In conclusion, PAX2 might be involved in the RIF.
In our study, we found that PHB was correlated negatively with PAX2. The PHB expression (mRNA or protein) in SHO group was much more remarkable than that in the GU group, and the PAX2 gene expression (mRNA or protein) in SHO group was markedly attenuated when compared with that in GU group. We speculated on the following mechanism: The PHB expression in GU group was weakened, which induced the generation of ROS . The increased ROS might up-regulate the gene expression of PAX2 [14,15], which regulated the expression of TGF-βl [48,49]. The disorder of TGF-βl might induce the expression of α-SMA, Col-IV and FN, and the increased TGF-βl could up-regulate the expression of cleaved Caspase-3 [50–52]. The over-expression of cleaved Caspase-3 was associated with cell apoptosis. Hence, the over-accumulation of ECM was observed and indexes of RIF and cell apoptosis were increased.
There was a rare report investigating whether or not PHB could affect the gene expression of PAX2. We found that less expression of PHB was associated with the increased gene expression of PAX2. The elevated expression of PAX2 took part in the development of RIF. We drew a hypothesis that there was a signal pathway between PHB and PAX2, and PHB could down-regulate the gene expression of PAX2 and could play a beneficial effect in the process of RIF. But, the detailed mechanism was not clear and the signal pathway in our hypothesis should be confirmed in vitro in the future.
Interestingly, as a nuclear transcription factor, the immunohistochemical staining points of PAX2 should gather in the nucleus, but the staining points of PAX2 could be found in cytoplasm in our study. Questions which need to be address in the future include: Whether the distribution of PAX2 was changed in the progression of renal interstitial fibrosis and how the PAX2 in the cytoplasm had a biological effect.
4. Materials and Methods
4.1. Animal Model
The Animal Care and Use Committee of Guangxi Medicial University approved all protocols. Eighty Wistar male rats (6-week-old) were purchased from the Experimental Animal center of Guangxi Medicial University, Nanning, China. The rats were randomly divided into two groups: sham operation group (SHO) and model group subjected to unilateral ureteral obstruction (GU); n = 40, respectively. The ureter was ligated at approximately 1 cm below the renal hilum with 3-0 silk suture. The abdominal wound was closed, and rats returned to the cages. Control rats underwent abdominal incision and approximation with no ligation of the ureter [53,54]. Twenty rats of the two groups were killed on 14-day and 28-day after surgery respectively and their renal tissue were collected for histological and molecular biology determination.
4.2. Renal Morphology
Sections were prepared on a microtome and stained with Masson’s trichrome staining and the RIF index was calculated using semi-quantitative evaluation as our previous description .
4.3. Immunohistochemical Analysis of the Protein Expressions of PHB, TGF-β1, α-SMA, Collagen-IV (Col-IV), Fibronectin (FN) and Cleaved Caspase-3
Renal tissue fixed with 4% buffered paraformaldehyde was embedded in paraffin, and 4 μm thick sections were stained. The positive area was measured quantitatively using a computer-aided manipulator (DMR+Q550, Leica Co., Wetzlar, Germany). For immunohistochemical analysis of PHB, TGF-β1, Col- IV, FN and cleaved Caspase-3, the sections were deparaffinized, washed with PBS, and treated with 3% H2O2 in methanol for 10 min. All sections were then incubated with anti-PHB antibody (1:300) (Neomarker lab, Co., Fremont, NE, USA), anti-PAX2 antibody (1:100) (ABSUN, Co., Missouri, MO, USA), anti-TGF-β1 antibody (1:100) (Zhongshan, Co., Beijing, China), anti-α-SMA antibody (ready-to-use kit) (Shanghai Changdao, Co., Inc., China), anti-Col-IV antibody (ready-to-use kit) (Bo Shide, Co., Wuhan, China), anti-FN antibody (1:50) (Zhongshan, Co., Beijing, China) and anti-cleaved Caspase-3 antibody (1:200) (Thermo Fisher Scientific, Co., Runcorn, UK), respectively. After incubation with second antibody immunoglobulin (Shanghai Changdao, Co., Shanghai, China), the sections were stained with diaminobenizidine (Maixin Bio, Co., Fuzhou, China). The staining of PHB, PAX2, TGF-βl, Col-IV, FN or cleaved Caspase-3 in renal tissue was measured. During evaluation of the interstitial areas, fields containing glomerular parts were ignored. All the evaluations were performed by two of the authors blinded to the experimental code.
4.4. Apoptosis Assay
Cell apoptosis was examined by the TdT mediated dUTP nick end labelling (TUNEL) assay (Roche Inc., Basel, Switzerland) as described previously [56,57]. Six slides from each kidney were evaluated for percentage of apoptotic cells by using the TUNEL assay. Then 10 watch fields, which didn’t include the glomerular parts, were chosen at random under microscope on each section. Brown staining of cell nuclei was considered apoptotic cells. Positive brown cells and total cells were counted. The formula for apoptosis index as the indicator of apoptosis was as follow [58–60]: cell apoptosis index = positive cells/total cells × 100%. The scores obtained by two investigators were averaged.
4.5. Real Time Reverse Transcription Polymerase Chain Reaction to Detect PHB, PAX2 and TGF-β1 mRNA Expressions in Renal Tissue
Total RNA was extracted from renal tissue using TRIzol (Beijing Tiangen, Co., China), and the operation procedure and method of calculation were the same as our previous description . The primers for PHB, PAX2, TGF-βl and internal control β-actin were as follows: F 5′-TGGCGTTAGCGGTTACAGGAG-3′ and R 5′-GAGGATGCGTAGTGTGATGTTGAC-3′ for PHB; F 5′-AAGCGACAGAACCCGACTATGT-3′ and R 5′-ACTCCTGTCCCTGCCCCAT-3′ for PAX2; F 5′-TGAGCACTGAA GCGAAAGCC-3′ and R 5′-GATTCAAGTCAACTGTGGAGCAAC-3′ for TGF-βl; F 5′-GCCCCTGAGGAGCACCCTGT-3′ and R 5′-ACGCTCGGTCAGGATCTTCA-3′ for β-actin. Real time reverse transcription polymerase chain reaction was performed on Applied Biosystems 7500 Fast Real-Time PCR System using SYBR Green as fluorescent dye [61,62]. The mRNA expression of PHB, PAX2, or TGF-βl was calculated as our previous description [63–65].
4.6. Statistical Analysis
The data are shown as mean ± standard deviation. Independent-Samples T Test was performed to determine the differences between SHO group and GU group, and the Pearson’s correlation coefficient was used to determine the relationships between the indicators for detection. A value of p < 0.05 was considered as significant . Statistical analysis was performed using the statistical package for social studies SPSS version 13.0 (SPSS, Chicago, IL, USA, 2004).
In conclusion, PHB appeared to play a protective role against RIF in UUO rats in our study, and PHB was associated with the gene expression of PAX2 and could alleviate the accumulation of ECM in renal interstitium; although the detailed mechanisms were not fully understood. Therefore, how to up-regulate the expression of PHB and down-regulate the PAX2 expression is very important for prevention of RIF, and PHB might be a potential therapeutic target for prevention of cell injury. This observation might offer some new insights to prevent the progression of RIF. However, cells culture in RTEC and so on, and inhibition of signaling pathway for PHB and PAX2 all need to be further investigated to explore the detailed mechanisms.
This study was supported by the Nature Science Foundation of China (No. 81060061), the Natural Science Foundation of the Guangxi Zhuang Autonomous Region (No. 0832121) and the Health Department of Guangxi Zhuang Autonomous Region (No. 200917).
- Conflict of InterestThe authors declare no conflict of interest.
- Xie, X.S.; Liu, H.C.; Wang, F.P.; Zhang, C.L.; Zuo, C.; Deng, Y.; Fan, J.M. Ginsenoside Rg1 modulation on thrombospondin-1 and vascular endothelial growth factor expression in early renal fibrogenesis in unilateral obstruction. Phytother Res 2010, 24, 1581–1587. [Google Scholar]
- Correa-Costa, M.; Semedo, P.; Monteiro, A.P.; Silva, R.C.; Pereira, R.L.; Goncalves, G.M.; Marques, G.D.; Cenedeze, M.A.; Faleiros, A.C.; Keller, A.C.; et al. Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis. PLoS One 2010, 5, 14298. [Google Scholar]
- Mishra, S.; Ande, S.R.; Nyomba, B.L. The role of prohibitin in cell signaling. FEBS. J 2010, 277, 3937–3946. [Google Scholar]
- Li, Q.F.; Liang, Y.; Shi, S.L.; Liu, Q.R.; Xu, D.H.; Jing, G.J.; Wang, S.Y.; Kong, H.Y. Localization of prohibitin in the nuclear matrix and alteration of its expression during differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid. Cell Mol. Neurobiol 2011, 31, 203–211. [Google Scholar]
- Liu, X.; Ren, Z.; Zhan, R.; Wang, X.; Wang, X.; Zhang, Z.; Leng, X.; Yang, Z.; Qian, L. Prohibitin protects against oxidative stress-induced cell injury in cultured neonatal cardiomyocyte. Cell Stress Chaperones 2009, 14, 311–319. [Google Scholar]
- Popova, E.N.; Pletjushkina, O.Y.; Dugina, V.B.; Domnina, L.V.; Ivanova, O.Y.; Izyumov, D.S.; Skulachev, V.P.; Chernyak, B.V. Scavenging of reactive oxygen species in mitochondria induces myofibroblast differentiation. Antioxid. Redox. Signal 2010, 13, 1297–1307. [Google Scholar]
- Guo, W.; Xu, H.; Chen, J.; Yang, Y.; Jin, J.W.; Fu, R.; Liu, H.M.; Zha, X.L.; Zhang, Z.G.; Huang, W.Y. Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1. Mol. Cell Biochem 2007, 295, 167–177. [Google Scholar]
- Luu, V.D.; Boysen, G.; Struckmann, K.; Casagrande, S.; Von Teichman, A.; Wild, P.J.; Sulser, T.; Schraml, P.; Moch, H. Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clin. Cancer Res 2009, 15, 3297–3304. [Google Scholar]
- Zhou, T.B.; Qin, Y.H.; Lei, F.Y.; Zhao, Y.J.; Huang, W.F. Association of PAX2 with cell apoptosis in unilateral ureteral obstruction rats. Ren. Fail 2012, 34, 194–202. [Google Scholar]
- Sehgal, R.; Sheibani, N.; Rhodes, S.J.; Belecky, A.T. BMP7 and SHH regulate PAX2 in mouse retinal astrocytes by relieving TLX repression. Dev. Biol 2009, 332, 429–443. [Google Scholar]
- Busse, A.; Rietz, A.; Schwartz, S.; Thiel, E.; Keilholz, U. An intron 9 containing splice variant of PAX2. J. Transl. Med 2009, 7, 36. [Google Scholar]
- Warchol, M.E.; Richardson, G.P. Expression of the PAX2 transcription factor is associated with vestibular phenotype in the avian inner ear. Dev. Neurobiol 2009, 69, 191–202. [Google Scholar]
- Bose, S.K.; Gibson, W.; Bullard, R.S.; Donald, C.D. PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer. Mol. Immunol 2009, 46, 1140–1148. [Google Scholar]
- Chen, Y.W.; Liu, F.; Tran, S.; Zhu, Y.; Hebert, M.J.; Ingelfinger, J.R.; Zhang, S.L. Reactive oxygen species and nuclear factor-kappa B pathway mediate high glucose-induced PAX2 gene expression in mouse embryonic mesenchymal epithelial cells and kidney explants. Kidney Int 2006, 70, 1607–1615. [Google Scholar]
- Zhang, S.L.; Chen, Y.W.; Tran, S.; Chenier, I.; Hebert, M.J.; Ingelfinger, J.R. Reactive oxygen species in the presence of high glucose alter ureteric bud morphogenesis. J. Am. Soc. Nephrol 2007, 18, 2105–2115. [Google Scholar]
- Murer, L.; Caridi, G.; Della, V.M.; Montini, G.; Carasi, C.; Ghiggeri, G.; Zacchello, G. Expression of nuclear transcription factor PAX2 in renal biopsies of juvenile nephronophthisis. Nephron 2002, 91, 588–593. [Google Scholar]
- Meng, L.; Qu, L.; Tang, J.; Cai, S.Q.; Wang, H.; Li, X. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, enhanced nitric oxide production in obstructed rat kidney. Vascul. Pharmacol 2007, 47, 174–183. [Google Scholar]
- Kim, D.S.; Kim, B.; Tahk, H.; Kim, D.H.; Ahn, E.R.; Choi, C.; Jeon, Y.; Park, S.Y.; Lee, H.; Oh, S.H.; Kim, S.Y. Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-kappaB activation. Biochem. Biophys. Res. Commun 2010, 403, 479–484. [Google Scholar]
- Kaneyama, T.; Kobayashi, S.; Aoyagi, D.; Ehara, T. Tranilast modulates fibrosis, epithelial-mesenchymal transition and peritubular capillary injury in unilateral ureteral obstruction rats. Pathology 2010, 42, 564–573. [Google Scholar]
- Cheng, J.; Truong, L.D.; Wu, X.; Kuhl, D.; Lang, F.; Du, J. Serum- and glucocorticoid-regulated kinase 1 is upregulated following unilateral ureteral obstruction causing epithelial-mesenchymal transition. Kidney Int 2010, 78, 668–678. [Google Scholar]
- Tang, R.; Yang, C.; Tao, J.L.; You, Y.K.; An, N.; Li, S.M.; Wu, H.L.; Liu, H.F. Epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells induced by urinary proteins requires the activation of PKC-alpha and betaI isozymes. Cell Biol. Int 2011, 35, 953–959. [Google Scholar]
- Wang, Q.L.; Tao, Y.Y.; Yuan, J.L.; Shen, L.; Liu, C.H. Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro. BMC. Cell Biol 2010, 11, 31. [Google Scholar]
- Minz, R.W.; Bakshi, A.; Chhabra, S.; Joshi, K.; Sakhuja, V. Role of myofibroblasts and collagen type IV in patients of IgA nephropathy as markers of renal dysfunction. Indian J. Nephrol 2010, 20, 34–39. [Google Scholar]
- Ma, F.Y.; Tesch, G.H.; Ozols, E.; Xie, M.; Schneider, M.D.; Nikolic-Paterson, D.J. TGF-β1-activated kinase-1 (TAK1) regulates inflammation and fibrosis in the obstructed kidney. Am. J. Physiol. Renal. Physiol 2011, 300, F1410–F1421. [Google Scholar]
- Barnes, J.L.; Gorin, Y. Myofibroblast differentiation during fibrosis: Role of NAD(P)H oxidases. Kidney Int 2011, 79, 944–956. [Google Scholar]
- Djamali, A.; Vidyasagar, A.; Yagci, G.; Huang, L.J.; Reese, S. Mycophenolic acid may delay allograft fibrosis by inhibiting transforming growth factor-beta1-induced activation of Nox-2 through the nuclear factor-kappaB pathway. Transplantation 2010, 90, 387–393. [Google Scholar]
- Zhou, G.; Li, C.; Cai, L. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am. J. Pathol 2004, 165, 2033–2043. [Google Scholar]
- Kelley, R.; Werdin, E.S.; Bruce, A.T.; Choudhury, S.; Wallace, S.M.; Ilagan, R.M.; Cox, B.R.; Tatsumi-Ficht, P.; Rivera, E.A.; Spencer, T.; et al. Tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease. Am. J. Physiol. Renal Physiol 2010, 299, 1026–1039. [Google Scholar]
- Mohamed, S.A.; Misfeld, M.; Hanke, T.; Charitos, E.I.; Bullerdiek, J.; Belge, G.; Kuehnel, W.; Sievers, H.H. Inhibition of caspase-3 differentially affects vascular smooth muscle cell apoptosis in the concave versus convex aortic sites in ascending aneurysms with a bicuspid aortic valve. Ann. Anat 2010, 192, 145–150. [Google Scholar]
- Cai, H.; Gu, Y.; Sun, Q.; Zeng, J.; Dong, N.; Zhao, G. Effect of hematoporphyrin monomethyl ether-mediated photodynamic therapy on hypertrophic scar fibroblasts. Photodermatol. Photoimmunol. Photomed 2011, 27, 90–96. [Google Scholar]
- Yue, Z.; She, R.P.; Bao, H.H.; Tian, J.; Yu, P.; Zhu, J.; Chang, L.; Ding, Y.; Sun, Q. Necrosis and apoptosis of renal tubular epithelial cells in rats exposed to 3-methyl-4-nitrophenol. Environ. Toxicol 2011. [Google Scholar] [CrossRef]
- He, W.; Wang, Y.; Zhang, M.Z.; You, L.; Davis, L.S.; Fan, H.; Yang, H.C.; Fogo, A.B.; Zent, R.; Harris, R.C.; et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J. Clin. Invest 2010, 120, 1056–1068. [Google Scholar]
- Li, L.; Zepeda-Orozco, D.; Black, R.; Lin, F. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am. J. Pathol 2010, 176, 1767–1778. [Google Scholar]
- Mandache, E.; Gherghiceanu, M.; Serafinceanu, C.; Penescu, M.; Mircescu, G. Myofibroblast involvement in tubular basement membrane remodeling in type II diabetic nephropathy. Rom. J. Morphol. Embryol 2011, 52, 75–79. [Google Scholar]
- Ko, K.S.; Tomasi, M.L.; Iglesias-Ara, A.; French, B.A.; French, S.W.; Ramani, K.; Lozano, J.J.; Oh, P.; He, L.; Stiles, B.L.; et al. Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice. Hepatology 2010, 52, 2096–2108. [Google Scholar]
- Sato, S.; Murata, A.; Orihara, T.; Shirakawa, T.; Suenaga, K.; Kigoshi, H.; Uesugi, M. Marine natural product aurilide activates the OPA1-mediated apoptosis by binding to prohibitin. Chem. Biol 2011, 18, 131–139. [Google Scholar]
- Muraguchi, T.; Kawawa, A.; Kubota, S. Prohibitin protects against hypoxia-induced H9c2 cardiomyocyte cell death. Biomed. Res 2010, 31, 113–122. [Google Scholar]
- Wu, H.Z.; Guo, L.; Mak, Y.F.; Liu, N.; Poon, W.T.; Chan, Y.W.; Cai, Z. Proteomics investigation on aristolochic acid nephropathy: A case study on rat kidney tissues. Anal. Bioanal. Chem 2011, 399, 3431–3439. [Google Scholar]
- Quan, H.; Peng, X.; Liu, S.; Bo, F.; Yang, L.; Huang, Z.; Li, H.; Chen, X.; Di, W. Differentially expressed protein profile of renal tubule cell stimulated by elevated uric acid using SILAC coupled to LC-MS. Cell Physiol. Biochem 2011, 27, 91–98. [Google Scholar]
- Sievers, C.; Billig, G.; Gottschalk, K.; Rudel, T. Prohibitins are required for cancer cell proliferation and adhesion. PLoS One 2010, 5, 12735. [Google Scholar]
- Dressler, G.R. Patterning and early cell lineage decisions in the developing kidney: The role of PAX genes. Pediatr. Nephrol 2011, 26, 1387–1394. [Google Scholar]
- Negrisolo, S.; Benetti, E.; Centi, S.; Vella, M.D.; Ghirardo, G.; Zanon, G.; Murer, L.; Artifoni, L. PAX2 gene mutations in pediatric and young adult transplant recipients: Kidney and urinary tract malformations without ocular anomalies. Clin. Genet 2011, 80, 581–585. [Google Scholar]
- Raca, G.; Jackson, C.A.; Kucinskas, L.; Warman, B.; Shieh, J.T.; Schneider, A.; Bardakjian, T.M.; Schimmenti, L.A. Array comparative genomic hybridization analysis in patients with anophthalmia, microphthalmia, and coloboma. Genet. Med 2011, 13, 437–442. [Google Scholar]
- Li, L.; Wu, Y.; Zhang, W. PAX2 re-expression in renal tubular epithelial cells and correlation with renal interstitial fibrosis of rats with obstructive nephropathy. Ren. Fail 2010, 32, 603–611. [Google Scholar]
- Benetti, E.; Caridi, G.; Vella, M.D.; Rampoldi, L.; Ghiggeri, G.M.; Artifoni, L.; Murer, L. Immature renal structures associated with a novel UMOD sequence variant. Am. J. Kidney Dis 2009, 53, 327–331. [Google Scholar]
- Mure, P.Y.; Gelas, T.; Dijoud, F.; Guerret, S.; Benchaib, M.; Hartmann, D.J.; Mouriquand, P. Complete unilateral ureteral obstruction in the fetal lamb. Part II: Long-term outcomes of renal tissue development. J. Urol 2006, 175, 1548–1558. [Google Scholar]
- Huang, B.; Pi, L.; Chen, C.; Yuan, F.; Zhou, Q.; Teng, J.; Jiang, T. WT1 and PAX2 re-expression is required for epithelial-mesenchymal transition in 5/6 nephrectomized rats and cultured kidney tubular epithelial cells. Cells Tissue Organs 2012, 195, 296–312. [Google Scholar]
- Fujita, H.; Hida, M.; Kanemoto, K.; Fukuda, K.; Nagata, M.; Awazu, M. Cyclic stretch induces proliferation and TGF-beta1-mediated apoptosis via p38 and ERK in ureteric bud cells. Am. J. Physiol. Renal Physiol 2010, 299, 648–655. [Google Scholar]
- Liu, S.; Cieslinski, D.A.; Funke, A.J.; Humes, H.D. Transforming growth factor-beta 1 regulates the expression of PAX2, a developmental control gene, in renal tubule cells. Exp. Nephrol 1997, 5, 295–300. [Google Scholar]
- Huang, S.; Zhang, F.; Miao, L.; Zhang, H.; Fan, Z.; Wang, X.; Ji, G. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Oncol. Rep 2008, 20, 1053–1059. [Google Scholar]
- Van der Heide, L.P.; Van Dinther, M.; Moustakas, A.; Ten, D.P. TGFbeta activates mitogen- and stress-activated protein kinase-1 (MSK1) to attenuate cell death. J. Biol. Chem 2011, 286, 5003–5011. [Google Scholar]
- Zheng, X.; Boerboom, D.; Carriere, P.D. Transforming growth factor-beta1 inhibits luteinization and promotes apoptosis in bovine granulosa cells. Reproduction 2009, 137, 969–977. [Google Scholar]
- Xie, P.; Sun, L.; Nayak, B.; Haruna, Y.; Liu, F.Y.; Kashihara, N.; Kanwar, Y.S. C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy. J. Am. Soc. Nephrol 2009, 20, 807–819. [Google Scholar]
- Zhang, D.; Sun, L.; Xian, W.; Liu, F.; Ling, G.; Xiao, L.; Liu, Y.; Peng, Y.; Haruna, Y.; Kanwar, Y.S. Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-beta/Smad activity. Lab. Invest 2010, 90, 436–447. [Google Scholar]
- Zhou, T.B.; Qin, Y.H.; Zhou, C.; Lei, F.Y.; Zhao, Y.J.; Chen, J.; Su, L.N.; Huang, W.F. Less expression of prohibitin is associated with increased Caspase-3 expression and cell apoptosis in renal interstitial fibrosis rats. Nephrology (Carlton) 2012, 17, 189–196. [Google Scholar]
- Hu, X.; Zhou, X.; He, B.; Xu, C.; Wu, L.; Cui, B.; Wen, H.; Lu, Z.; Jiang, H. Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Eur. J. Pharmacol 2010, 638, 84–89. [Google Scholar]
- Ha, T.; Hua, F.; Liu, X.; Ma, J.; McMullen, J.R.; Shioi, T.; Izumo, S.; Kelley, J.; Gao, X.; Browder, W.; et al. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovasc. Res 2008, 78, 546–553. [Google Scholar]
- Li, W.; Wang, J.; Jiang, H.R.; Xu, X.L.; Zhang, J.; Liu, M.L.; Zhai, L.Y. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo. Int. J. Mol. Sci 2011, 12, 668–681. [Google Scholar]
- Lai, J.Y.; Li, Y.T.; Wang, T.P. In vitro response of retinal pigment epithelial cells exposed to chitosan materials prepared with different cross-linkers. Int. J. Mol. Sci 2010, 11, 5256–5272. [Google Scholar]
- Zhou, T.B.; Qin, Y.H.; Li, Z.Y.; Xu, H.L.; Zhao, Y.J.; Lei, F.Y. All-trans retinoic Acid treatment is associated with prohibitin expression in renal interstitial fibrosis rats. Int. J. Mol. Sci 2012, 13, 2769–2782. [Google Scholar]
- Capozzi, V.; Arena, M.P.; Crisetti, E.; Spano, G.; Fiocco, D. The hsp 16 gene of the probiotic lactobacillus acidophilus is differently regulated by salt, high temperature and acidic stresses, as revealed by reverse transcription quantitative PCR (qRT-PCR) analysis. Int. J. Mol. Sci 2011, 12, 5390–5405. [Google Scholar]
- Liu, X.D.; Fan, R.F.; Zhang, Y.; Yang, H.Z.; Fang, Z.G.; Guan, W.B.; Lin, D.J.; Xiao, R.Z.; Huang, R.W.; Huang, H.Q.; et al. Down-regulation of telomerase activity and activation of caspase-3 are responsible for tanshinone I-induced apoptosis in monocyte leukemia cells in vitro. Int. J. Mol. Sci 2010, 11, 2267–2280. [Google Scholar]
- Zhou, T.B.; Qin, Y.H.; Ou, C.; Lei, F.Y.; Su, L.N.; Huang, W.F.; Zhao, Y.J. All-trans retinoic acid can regulate the expressions of gelatinases and apolipoprotein E in glomerulosclerosis rats. Vascul. Pharmacol 2011, 55, 169–177. [Google Scholar]
- Zhou, T.B.; Qin, Y.H.; Lei, F.Y.; Su, L.N.; Zhao, Y.J.; Huang, W.F. All-trans retinoic acid regulates the expression of apolipoprotein E in rats with glomerulosclerosis induced by Adriamycin. Exp. Mol. Pathol 2011, 90, 287–294. [Google Scholar]
- Zhou, T.B.; Qin, Y.H.; Lei, F.Y.; Su, L.N.; Zhao, Y.J.; Huang, W.F. Less gelatinases is associated with apolipoprotein E accumulation in glomerulosclerosis rats. Histol. Histopathol 2012, 27, 249–256. [Google Scholar]
- Zhou, T.B.; Qin, Y.H.; Lei, F.Y.; Su, L.N.; Zhao, Y.J.; Huang, W.F. apoE expression in glomerulus and correlation with glomerulosclerosis induced by adriamycin in rats. Ren. Fail 2011, 33, 348–354. [Google Scholar]
© 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).